Pursuant to the provisions of Regulation 30(6) of the SEBI (LODR) Regulation, 2015, we would like to inform you that at the meeting of Board of Directors of M/s Phyto Chem (India) Limited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Phyto Chem (India) Limited's Board of Directors met on 11 August 2025 (3:00 PM to 6:45 PM) and approved multiple items. The Board approved the unaudited financial results for Q1 FY26 (quarter ended 30 June 2025), though specific numbers were not disclosed in this filing. Key governance changes include the retirement of Dr. Y. Venkateswarlu, the cessation of Independent Director Dr. G.S.R. Anjaneyulu (after completing two consecutive terms), and the resignation of Non-Executive Director Mr. P. Anjaneyulu. Three new directors were appointed: Mr. K. Srinivasa Rao (Non-Executive), Mr. Sreemannarayana Yarlagadda (Executive), and Mr. Sudhakar Nadendla (Independent), along with the re-appointment of two Independent Directors pending shareholder approval. Notably, the Board decided to withdraw the proposal to increase the Authorised Share Capital, citing current market conditions. The Board also approved the 36th AGM date, notice, e-voting arrangements, and the Directors' Report for FY25.
The withdrawal of the authorised share capital increase means no near-term equity dilution is planned, which is positive for existing shareholders but signals caution from management about fundraising prospects. The board reshuffle, including a new Executive Director, may bring strategic shifts, while the Q1 results announcement could move the stock once numbers are released.